Needham & Company’s 11th Annual Healthcare Conference is a high-impact forum for institutional investors and venture capital firms to hear the latest updates from senior management teams of both public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology and Diagnostics sectors. Over the course of two days, attendees can attend company presentations, as well as expert sessions with clinical and industry professionals. One-on-one meetings with companies will be available for qualified institutional investors and venture capital firms. Please contact your Needham salesperson for registration details as space will be limited.

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, will be presenting on April 4, 2012.